Keywords: allergan, 4th-qtr, profit, falls, sales, drop, fourth-quarter
Allergan's 4th-qtr profit falls 6% on 3% sales drop
Article | 16 February 2009
Allergan's fourth-quarter 2008 profit fell 6% to $150.6 million, or $0.50 per share, as revenue decreased 3% to $1.06 billion. The California, USA-based company, which makes ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
